Support teaching, research, and patient care.
Michael Ma, MD is an Assistant Professor of Cardiothoracic Surgery in the Division of Pediatric Cardiac Surgery at Stanford University. His practice encompasses all aspects of congenital heart disease, with an emphasis on neonates, complex biventricular repair, pulmonary artery reconstruction, and heart failure. Dr. Ma’s translational research lab utilizes biomechanical engineering principles to optimize existing and develop de novo surgical and endovascular therapies in the ongoing treatment of complex heart defects.
Our lab aims to understand the biomechanics that govern a wide spectrum of congenital heart defects, and how those biomechanics change with contemporary operative repair strategies. We simulate operations virtually via CFD, and in ex vivo and in vivo animal models, and analyze how the changes we make alter fluid flow, pressure, and stresses throughout the system. We hope that these experiments can impact and optimize existing techniques that translate quickly to the operating room.
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
COMPASS is a prospective multicenter randomized interventional trial. Participants with
ductal-dependent pulmonary blood flow will be randomized to receive either a
systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be
performed by center and by single vs. two ventricle status. Participants will be followed
through the first year of life.
View full details
The Medtronic Harmony™ Transcatheter Pulmonary Valve Clinical Study
The purpose of this study is to further evaluate the safety and effectiveness of the Harmony™
TPV system. The Pivotal/CAS phases of the study have transitioned into a post-approval study
to confirm the long-term functionality of transcatheter implantation of the Medtronic Harmony
Stanford is currently not accepting patients for this trial.
For more information, please contact SPECTRUM, .